论文信息 - The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism - 字舞流文

The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism

Marc P. Bonaca | P. Ellinor | A. Keech | R. Giugliano | M. Sabatine | P. Sever | S. Lubitz | B. Gencer | M. O’Donoghue | C. Roselli | T. Pedersen | C. Ruff | N. Marston | G. Melloni | Yared Gurmu